EpilepsyGTx
EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy.
About EpilepsyGTx
EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy (FRE).
Company Facts
- Headquarters
- Canterbury
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00001_00010
- Funding Stage
- early_stage_venture
- Total Funding
- $43,000,000
- Last Funding Type
- series_a
- Last Funding Date
- 2025-12-10
- Website
- epilepsygtx.com
Industries & Categories
Biotechnology, Clinical Trials, Medical
Social Links
Canonical: https://fsome.com/organization/epilepsygtx-85241 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.